Professor Steve Rannard

Long-acting injectable medicine as potential route to COVID-19 therapy

April 14, 2021

Liverpool launches new Centre of Excellence for Long-acting Therapeutics

January 12, 2021

University and Scott Bader Company Ltd announce joint venture to develop a novel polymer chemistry platform

June 30, 2020

£24m boost for revolutionary long-acting medicine research

January 31, 2020

Novel nano-engineered ‘microneedles’ to help HIV drug delivery

August 19, 2019

University spin out company appoints Executive Chairman

June 10, 2019

£3m boost for Liverpool advanced materials and healthcare research

March 27, 2018

£2.2m collaboration to develop new approaches for HIV therapy

September 15, 2017

New partnership paves way for improved HIV treatments through nanomedicine

December 1, 2015

Long acting HIV drugs to be developed

September 10, 2014